Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 15, 2003 - Issue 5
32
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Hospitalization for depressive syndrome in a cohort of HIV-infected patients contaminated through injecting drug use: MANIF 2000 cohort, France, 1995-1999

, , , , , & show all
Pages 729-734 | Published online: 27 May 2010

References

  • AALEN , O.O. , FAREWELL , V.T. , DEANGELIS , D. , DAY , N.E. and GILL , O.N. 1999 . New therapy explains the fall in AIDS incidence with a substantial rise in number of persons on treatment expected . AIDS , 13 : 103 – 108 .
  • ALLARDICE , G.M. , MCMENAMIN , J.J. , PARPIA , T. , GIBBS , J. , MCSHARRY , C. and WHITELAW , J. 1998 . The recent impact of antiretroviral combination therapy on CD4 counts, AIDS and death in HIV-infected persons: routine HIV surveillance in Scotland . International Journal of STD and AIDS , 9 : 561 – 566 .
  • ANGELINO , A.F. and TREISMAN , G.J. 2001 . Management of psychiatric disorders in patients infected with human immunodeficiency virus . Clinical Infectious Diseases , 33 (6) : 847 – 856 .
  • ATKINSON , J.H. and GRANT , I.I. 1997 . Mood disorder due to human immunodeficiency virus: yes, no or maybe? . Seminal Clinical Neuropsychiatry , 2 (4) : 276 – 284 .
  • BOUHNIK , A.D. , MOATTI , J.P. , VLAHOV , D. , GALLAIS , H. , DELLAMONICA , P. and OBADIA , Y. 2002 . Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users . Journal of Epidemiology and Community Health , 56 (5) : 349 – 353 .
  • CARRIERI , M.-P. , MOATTI , J.-P. , VLAHOV , D. , OBADIA , Y. , REYNAUD-MAURUPT , C. , CHESNEY , M. and THE A.T.M.S. GROUP . 1999 . Access to antiretroviral treatment among French HIV-infected injection drug users (IDUs): theinfluence of continued drug use . Journal of Epidemiology and Community Health , 53 : 4 – 8 .
  • CIESLA , J. and ROBERTS , J. 2001 . Meta-analysis of the relationship between HIV infection and risk for depressive disorders . American Journal of Psychiatry , 158 (5) : 725 – 730 .
  • DARKE , S. 1998 . Self-report among injecting drug users: a review . Drug and Alcohol Dependence , 51 : 253 – 263 .
  • GOLLUB , E.L. , REY , D. , OBADIA , Y. and MOATTI , J.P. 1998 . Gender differences in risk behaviors among HIV-persons with an IDU history: the link between partner characteristics and women's higher drug-sex risks. The Manif 2000 Study Group . Sexually Transmitted Diseases , 25 (9) : 483 – 488 .
  • GRASSI , L. , MONDARDINI , D. , PAVANATI , M. , SIGHINOLFI , L. , SERRA , A. and GHINELLI , F. 2001 . Suicide probability and psychosocial morbidity secondary to HIV infection: a control study of HIV-seropositive, hepatitis C virus (HCV)-seropositive and HIV/HCV seronegative injecting drug users . Journal of Affective Disorders , 64 : 195 – 202 .
  • GREENFIELD , L. , BIGELOW , G. and BROONER , R. 1995 . Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors . Drug and Alcohol Dependence , 39 : 91 – 98 .
  • HAASTRECHT , H. , VAN DEN HOEK , A. and COUTINHO , R. 1994 . High mortality among HIV-infected injecting drug users without AIDS diagnosis: implications for HIV infection epidemic modellers? . AIDS , 8 : 363 – 366 .
  • ICKOVICS , J.R. , HAMBURGER , M.E. , VLAHOV , D. , SCHOENBAUM , E.E. , SCHUMAN , P. , BOLAND , R.J. and MOORE , J. 2001 . Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study . Journal of the American Medical Association , 285 (11) : 1466 – 1474 .
  • JOHNSON , J. , RABKIN , J. , LIPSITZ , J. , WILLIAMS , J. and REMIEN , R. 1999 . Recurrent major depressive disorder among human immunodeficiency virus (HIV)-positive and HIV-negative intravenous drug users: findings of a 3-year longitudinal study . Comprehensive Psychiatry , 40 (1) : 31 – 34 .
  • KALICHMAN , S. , HECKMAN , T. , KOCHMAN , A. , SIKKEMA , K. and BERGHOLTE , J. 2000 . Depression and thoughts of suicide among middle-aged and older persons living with HIV-AIDS . Psychiatric Services , 51 (7) : 903 – 907 .
  • KNOWLTON , A. , LATKIN , C. , SCHROEDER , J. , HOOVER , D. , ENSMINGER , M. and CELENTANO , D. 2001 . Longitudinal predictors of depressive symtoms among low income injecting drug users . AIDS Care , 13 (5) : 549 – 559 .
  • LATKIN , C. and VLAHOV , D. 1998 . Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users . Addiction , 93 : 1191 – 1197 .
  • LAURICHESSE , H. , MORTIMER , J. , EVANS , B. and FARRINGTON , C. 1998 . Pre-AIDS mortality in HIV-infected individuals in England, Wales and Northern Ireland, 1982-1996 . AIDS , 12 : 651 – 658 .
  • LIANG , K. and ZEGER , S. 1986 . Longitudinal data analysis using generalized linear models . Biometrika , 73 : 13 – 22 .
  • MALBERGIER , A. and DE ANDRADE , A. 2001 . Depressive disorders and suicide attempts in injecting drug users with and without HIV infection . AIDS Care , 13 (1) : 141 – 150 .
  • MCNAUGHTON , M. , PATTERSON , T. , IRWIN , M. and GRANT , I. 1992 . The relationship of life adversity, social support, and coping to hospitalization with major depression . Journal of Nervous Mental Diseases , 180 (8) : 491 – 497 .
  • MESSIAH , A. , LOUNDOU , A.D. , MASLIN , V. , LACARELLE , B. and MOATTI , J.-P. 2001 . Physician recognition of active drug use in HIV-infected patients is lower than validity of patient's self-reported drug use . Journal of Pain and Symptom Management , 21 : 103 – 112 .
  • MOATTI , J.P. , CARRIERI , M.P. , SPIRE , B. , GASTAUT , J.A. , CASSUTO , J.P. and MOREAU , J. 2000 . Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 Study Group . AIDS , 14 (2) : 151 – 155 .
  • MOCROFT , A. , VELLA , S. , BENFIELD , T. , CHIESI , A. , MILLER , V. , GARGALIANOS , P. , D'ARMINIOMONFORTE , A. , YUST , I. , BRUUN , J. , PHILLIPS , A. and LUNDGREN , J. 1998 . Changing patterns of mortality across Europe in patients infected with HIV-1 . The Lancet , 352 : 1725 – 1730 .
  • MOUTON , Y. , ALFANDARI , S. , VALETTE , M. , CARTIER , F. , DELLAMONICA , P. , HUMBERT , G. , LANG , J. , MASSIP , P. , MECHALI , D. , LECLERCQ , P. , MODAI , J. and PORTIER , H. 1997 . Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 french AIDS reference centres . AIDS , 11 : F101 – F105 .
  • PALEPU , A. , STRATHDEE , S. , HOGG , R. , ANIS , A. , RAE , S. , CORNELISSE , P. , PATRICK , D. , O'SHAUGHNESSY , M. and SCHECHTER , M. 1999 . The social determinants of emergency department and hospital use by injection drug users in Canada . Journal of Urban Health , 76 (4) : 409 – 418 .
  • PENZAK , S. , REDDY , Y. and GRIMSLEY , S. 2000 . Depression in patients with HIV infection . American Journal of Health-System Pharmacy , 57 (4) : 376 – 386 .
  • REYNAUD-MAURUPT , C. , CARRIERI , M.P. , GASTAUD , J.A. , PRADIER , C. , OBADIA , Y. and MOATTI , J.P. 2000 . Impact of drug maintenance treatment on injection practices among French HIV-infected IDUs. The MANIF 2000 Study Group . AIDS Care , 12 (4) : 461 – 470 .
  • SHERBOURNE , C. , HAYS , R. , FLEISHMAN , J. , VITIELLO , B. , MAGRUDER , K. , BING , E. , MCCAFFREY , D. , BURNAM , A. , LONGSHORE , D. , EGGAN , F. , BOZZETTE , S. and SHAPIRO , M. 2000 . Impact of psychiatric conditions on healthrelated quality of life in persons with HIV infection . American Journal of Psychiatry , 157 (2) : 248 – 254 .
  • VAN AMEIJDEN , E. , KROL , A. , VLAHOV , D. , FLYNN , C. , VAN HAASTRECHT , H. and COUTINHO , R. 1999 . Pre-AIDS mortality and morbidity among injection drug users in Amsterdam and Baltimore: an ecological comparison . Substance Use & Misuse , 34 (6) : 845 – 865 .
  • VAN HAASTRECHT , H. , VAN AMEIJDEN , E. , VAN DEN HOEK , J. , MIENTJES , G. , BAX , J. and COUTINHO , R. 1996 . Predictors of mortality in the Amsterdam cohort of Human Immunodeficiency virus (HIV)-positive and HIVnegative drug users . American Journal of Epidemiology , 143 : 380 – 391 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.